ImageneBio (IMA) EBITDA Margin (2020 - 2025)
ImageneBio (IMA) recorded EBITDA Margin of -749.13% in Q1 2025.
Powered by 
Analysis
ImageneBio (IMA) EBITDA Margin (2020 - 2025) Analysis & Trends
For FY2023, ImageneBio reported EBITDA Margin of -812.19%, down 363.01 percentage points from FY2022.
- Annual EBITDA Margin has a three-year change of -331.24 percentage points (FY2020 to FY2023).
- Across earlier years, EBITDA Margin came in at -449.18% in FY2022 (-340.76 pp), -108.42% in FY2021 (+372.53 pp) and -480.95% in FY2020.
- The Q1 2025 figure is the lowest quarterly EBITDA Margin since Q4 2023.
- On a year-over-year basis, EBITDA Margin rose in two of the last four quarters, with an average year-over-year change of +437.71 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 39980.77 percentage points in Q4 2021, against a drop of 5091.15 percentage points in Q2 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,139.37 Bn | 1,107.95 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 618.39 Bn | 536.92 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 508.07 Bn | 481.19 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 367.07 Bn | 321.44 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.65 Bn | 262.64 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 263.08 Bn | 236.77 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 236.65 Bn | 192.05 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 192.73 Bn | 166.92 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 171.28 Bn | 117.93 Bn | 10.94 Bn | 39.16% |
| 10 | ImageneBio | 35.22 Mn | -452.41 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -749.13% |
| Sep 30, 2024 | -55.60% |
| Dec 31, 2023 | -3,278.15% |
| Sep 30, 2023 | -1,625.40% |
| Jun 30, 2023 | -910.58% |
| Mar 31, 2023 | -287.67% |
| Dec 31, 2022 | -273.47% |
| Sep 30, 2022 | -275.90% |
| Jun 30, 2022 | -5,445.81% |
| Mar 31, 2022 | -495.92% |
| Dec 31, 2021 | 14.62% |
| Sep 30, 2021 | -385.00% |
| Jun 30, 2021 | -354.66% |
| Mar 31, 2021 | -276.91% |
| Dec 31, 2020 | -39,966.15% |
| Sep 30, 2020 | -216.79% |
| Jun 30, 2020 | -161.37% |
| Mar 31, 2020 | -220.08% |
API Access
ImageneBio EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "IMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();